NFKB1 and Chagas disease: Since benznidazole (BZ), the reference drug for the treatment of Chagas disease, has previously been demonstrated to be immunomodulatory over the NF-kB pathway [31], the combination of this drug with compound 1 was studied over the Raw-Blue cell line stimulated with LPS.